Company Monitoring Page for AstraZeneca

latest headlines for company on cafepharma

Biotechs Coming Off One Of The Busiest Weeks In Recent Memory
Yahoo/Benzinga
Tue, 09/15/15 - 09:04 am
Tags:
biotech, Gilead Sciences, Akebia, Vitae, Clovis Oncology, AstraZeneca, Bristol-Myers Squibb, Flexion, Tetraphase Pharmaceuticals
The Medicare Gravy Train Into Big Pharma's Pockets Keeps Growing
Seeking Alpha
Mon, 09/14/15 - 10:57 am
Tags:
Medicare, Medicaid, AstraZeneca, Gilead Sciences, Merck, Pfizer, Sanofi
Isis-AstraZeneca Collaboration For Antisense Drugs Gets HSR Clearance
NASDAQ.com
Sat, 09/12/15 - 01:21 pm
Tags:
Isis Pharmaceuticals, AstraZeneca, antisense, R&D
AstraZeneca picks up discarded Amgen plant as part of its biologics expansion
Fierce Pharma
Fri, 09/11/15 - 10:48 am
Tags:
Amgen, AstraZeneca, drug manufacturing, biologics
AZ's high-powered Crestor could gain from payer limits on PCSK9 meds
Fierce Pharma Marketing
Fri, 09/11/15 - 09:55 am
Tags:
AstraZeneca, Crestor, PCSK9 inhibitors, drug pricing, Repatha, Praluent, Amgen, Regeneron, Sanofi
Clovis leaps as AstraZeneca's AZD9291 disappoints on lung cancer
Fierce Biotech
Thu, 09/10/15 - 05:54 pm
Tags:
Clovis Oncology, AstraZeneca, AZD9291, non-small cell lung cancer
AstraZeneca nabs priority review voucher as Wellstat bags FDA OK
Fierce Biotech
Tue, 09/8/15 - 08:21 am
Tags:
AstraZeneca, FDA, Wellstat, priority review, review vouchers, Xuriden
New data expected at lung-cancer conference on experimental drug combos
Medical Marketing and Media
Fri, 09/4/15 - 09:01 am
Tags:
lung cancer, Opdivo, Yervoy, Bristol-Myers Squibb, tremelimumab, MEDI4736, AstraZeneca, Roche, atezolizumab
FDA approves expanded indication for AstraZeneca's blood thinner
Yahoo/Reuters
Thu, 09/3/15 - 06:31 pm
Tags:
FDA, AstraZeneca, Brilinta, bloodthinners
AstraZeneca backs $80M round for ADC's antibody warhead tech
Fierce Biotech
Wed, 09/2/15 - 10:14 am
Tags:
AstraZeneca, ADC Therapeutics, antibody-drug conjugate
AstraZeneca sales team revving up for new Brilinta marketing push
Fierce Pharma Marketing
Tue, 09/1/15 - 06:44 pm
Tags:
AstraZeneca, Brilinta
AstraZeneca auctions off troubled psoriasis drug to Valeant in $445M deal
Fierce Biotech
Tue, 09/1/15 - 09:55 am
Tags:
AstraZeneca, Valeant Pharmaceuticals, psoriasis, brodalumab
AstraZeneca’s Profitability for 2Q15
Yahoo/Market Realist
Sat, 08/29/15 - 08:58 am
Tags:
AstraZeneca
FDA warns of severe joint pain risk with DPP-4 diabetes drugs
Yahoo/Reuters
Fri, 08/28/15 - 05:52 pm
Tags:
FDA, diabetes, joint pain, DPP-4 inhibitor, Merck, Januvia, Onglyza, AstraZeneca, Takeda, Boehringer Ingelheim
AstraZeneca’s Oncology Segment: How Did It Perform in 2Q15?
Yahoo/Market Realist
Fri, 08/28/15 - 08:12 am
Tags:
AstraZeneca, oncology
AstraZeneca uses snails and overstuffed luggage to push OIC awareness--and its branded solution
Fierce Pharma Marketing
Thu, 08/27/15 - 09:24 am
Tags:
AstraZeneca, OIC, Monvantik, opiod-induced constipation, Daiichi Sankyo
AstraZeneca’s CVMD Segment: How Did It Perform in 2Q15?
Yahoo/Market Realist
Wed, 08/26/15 - 10:43 am
Tags:
AstraZeneca, cardiovascular disease, metabolic disorders, Onglyza, Crestor, Brilinta
AstraZeneca Oncology Partnerships To Help Recover Sales
Bidness ETC
Tue, 08/25/15 - 09:43 am
Tags:
AstraZeneca, oncology, Pfizer, Peregrine Pharmaceuticals, Heptares Therapeutics, Mirati Therapeutics, Juno Therapeutics
AstraZeneca lures Sean Bohen from Genentech to fill top R&D post
Fierce Biotech
Mon, 08/24/15 - 11:25 am
Tags:
AstraZeneca, R&D, Genentech
Lilly, Sanofi, Novo among many pharma players to throw off big price gains in H1
Fierce Pharma
Sat, 08/22/15 - 08:48 am
Tags:
Sanofi, Novo Nordisk, Eli Lilly, AstraZeneca, GSK, JNJ, stock prices

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.